[Weekly GDIN] Scaling Tech Corridors in Spain, Brazil & Beyond

GDIN Accelerates Cross-Border Tech Corridors Across Spain's Innovation Hubs

From October 19 to 23, GDIN conducted a strategic mission across Spain—spanning Valencia, Castelló, and Tenerife—to advance active pilot programs, explore cross-border enterprise deployments, and establish institutional frameworks connecting Korean innovative companies with Spain’s industrial ecosystems.

🤝 Regional Ecosystem Integration & Market Access via Valencia

In Valencia, GDIN met with Startup Valencia to structure long-term commercial entry points for Korean ventures into the Southern European innovation market:

• VDS 2027 Pipeline: Discussions established initial pathways for Korean technology startups to participate in the upcoming Valencia Digital Summit (VDS) 2027, aligning cohort roadmaps with regional corporate buyers and Spanish venture capital networks.

• Cross-Border Market Expansion: The dialogue focused on localized landing infrastructure, facilitating corporate partnerships to help Korean scale-ups de-risk their broader European expansion.

🌱 Industrial Decarbonization & Utility Infrastructure in Castelló

In Castelló de la Plana, the delegation evaluated operational milestones across environmental data management and municipal water utilities:

• i-ESG × NEALIS Commercial Progress: GDIN reviewed the field deployment of Korean ESG data-tech venture i-ESG, which is executing a joint initiative with Spanish environmental consultancy NEALIS to deliver localized environmental footprint calculation and sustainability compliance software.

• Utility Collaboration with FACSA: Strategic consultations with FACSA (Ciclo Integral del Agua)—a premier Spanish integrated water utility—identified technical operational needs across regional water infrastructure, shaping concrete parameters for bilateral pilot validations.

🚀 Enterprise Commercialization & Deep-Tech Scouting in Tenerife

Operationalizing its institutional Memorandum of Understanding (MoU) with Fundación Géiser, GDIN structured enterprise-level B2B engagements across the Canary Islands:

• Municipal Integration Pilots: i-ESG pitched its proprietary carbon accounting and ESG analytics suite to leading regional operators, including water management authority CANARAGUA and environmental services provider Martínez Cano Canarias, exploring commercial pilot integrations.

• Frontier Deep-Tech Sourcing: At the Instituto Tecnológico y de Energías Renovables (ITER), the delegation evaluated technologies across emerging ventures IMPRESSORA, Kanara Labs, and Light Bridges. Technical walk-throughs at ARQUIMEA Research Center and optical innovator Wooptix identified high-synergy collaborative R&D pathways between Korean institutions and Spanish research assets.

Through synchronized engagements across regional utilities, corporate stakeholders, and research centers, GDIN continues to build actionable commercial pipelines, connecting Korean software and deep-tech ventures with Europe's industrial and environmental transformation.

GDIN Hosts B2B Matchmaking for Korea–Brazil Partnerships

GDIN, in strategic collaboration with regional investment promotion agency Invest Paraná, hosted a targeted enterprise matchmaking session connecting leading Brazilian industry players with Korean technology and manufacturing companies. The session established direct commercial pipelines into Latin America’s largest economy across architectural surfaces, omnichannel retail, and generative AI education.

🤝 Strategic Alignment & Institutional Framework with Invest Paraná

Co-hosted alongside Eduardo Komatsu of Invest Paraná, the initiative evaluated actionable mechanisms to de-risk market entry for Korean innovators expanding into South America:

• Bilateral Commercialization Roadmap: GDIN outlined its multi-phase Latin American strategy, detailing structured frameworks for cross-border technology deployment, local joint ventures, and distribution networks.

• Enterprise-Level Market Access: Discussions focused on connecting Korean technical capabilities directly with regional supply chain requirements, facilitating targeted regulatory navigation and commercial validation.

📋 Cross-Border Enterprise Synergies Across Materials & AI SaaS

The session facilitated focused B2B discussions between Brazilian corporate leaders and Korean solution providers:

• Advanced Surfaces & Retail Transformation: JAEYOUNG, a specialist in high-performance PVC and architectural interior flooring materials, engaged in commercial evaluations with Portobello Grupo—a major Brazilian architectural surfaces and design group seeking advanced materials and digital visualization technologies—and Gouvêa & Spheria Trade Missions, exploring localized distribution models across Brazil’s retail architecture and omnichannel sectors.

• AI-Powered Workforce & Educational Infrastructure: FrameOut, a developer of AI-driven educational content generation, automated evaluation, and curriculum-mapping SaaS, presented its enterprise architecture to Redelê, a prominent Brazilian digital learning and corporate workforce development platform, initiating discussions on localized pilot integration.

By bridging high-value Korean innovators with established Brazilian corporate networks, GDIN continues to scale its Latin American corridor, converting bilateral dialogue into tangible commercial contracts and cross-border enterprise deployments.

GDIN Showcases Clinically Validated K-Healthcare Innovators at IHMC 2026

On October 28, GDIN hosted the 'Startup Showcase' at the 6th International Healthcare & Medtech Conference (IHMC 2026), convened at the Bundang Seoul National University Hospital (SNUH) Healthcare Innovation Park. The showcase connected six high-potential Korean digital healthcare and medtech innovators with global hospital networks, institutional investors, and strategic partners.

📋 Clinically Validated Ventures & Enterprise Solutions

The showcase convened growth-stage enterprises deploying specialized AI, diagnostic platforms, and smart care infrastructure:

• Monit: Smart senior-care telemetry platform combining non-contact sensors and AI pattern recognition to detect incontinence in real time, mitigating decubitus ulcer (bedsore) risks across institutional care facilities in Korea, Japan, and Singapore.

• QUVE: Dental Care-as-a-Service (CaaS) architecture ('NeXways') linking global dental clinics with South Korea's precision lab manufacturing alongside mobile clinic deployment models.

• Exosystems: AI digital biomarker engine that compresses motor function assessment time for musculoskeletal and neurological patients from 90 to under 5 minutes, backed by an FDA-registered telerehabilitation platform.

• Zeroweb: Non-contact IoT ambient-sensing platform ('Carebell') tracking senior Activities of Daily Living (ADL) to prevent solitary deaths and facilitate hospital-to-home post-discharge patient monitoring.

• InnoOne: Multi-omics precision oncology engine delivering Whole Genome Sequencing (WGS) data interpretation within two weeks to match optimal targeted therapies and uncover novel drug discovery targets.

• Asleep: Software-as-a-Medical Device (SaMD) solution ('ApnoTrack') screening obstructive sleep apnea solely via smartphone microphone acoustic breathing telemetry, paired with an integrated smart bedroom climate control system ('SleepHub').

Following the showcase, GDIN is establishing targeted collaborative tracks connecting participating enterprises with overseas hospital networks to accelerate regulatory clearance and commercial deployment across global healthcare markets.

🚀 Inocras: The precision oncology and bioinformatics company executed a strategic partnership with UAE-based global healthcare network M42 to deploy its minimal residual disease (MRD) liquid biopsy surveillance solution. The collaboration initiates a pilot program at Cleveland Clinic Abu Dhabi utilizing 'MRDVision™'—a whole-genome sequencing-based assay engineered to detect ultra-low concentrations of circulating tumor DNA in high-risk breast cancer patients. By compiling regional clinical utility and health-economic data, the initiative aims to establish a formal pathway for the assay’s inclusion in the UAE’s national healthcare system. 

🚀 P2ACH AI: The retail-tech innovator entered the final phase of a field PoC with Japanese retail giant FamilyMart to deploy its specialized computer vision solution, 'RAX'. Leveraging proprietary vision AI algorithms, RAX automates shelf-display compliance, out-of-stock monitoring, and store staff route optimization to relieve on-site operational burdens amid Japan's acute retail labor shortages. Building on the initial trial results, the two companies are evaluating an expanded rollout to up to 500 locations across FamilyMart’s 16,300-store nationwide network, targeting commercial deployment in Q1 2027.

🚀 HyperAccel: The AI semiconductor startup announced plans to initiate mass production of 10,000 units of 'Bertha 500'—its proprietary LPU accelerator optimized for LLM inference—by late 1H 2027. Bypassing cost-prohibitive HBM, the architecture integrates low-power mobile DRAM (LPDDR5X) with 32 compute cores and a proprietary data-reuse layout to optimize total cost of ownership and operational energy efficiency. Backed by completed PoC milestones with co-developer Naver Cloud, the startup is accelerating its market entry into next-generation hyperscale enterprise data centers. 

HME Square: Pain-Free Glucose Monitoring Powered by Light and Sound

With global diabetes prevalence exceeding 580 million adults, continuous glycemic tracking has become an essential pillar of everyday metabolic health. Yet conventional monitoring remains tethered to structural friction: patients must either endure painful fingersticks several times a day or wear invasive needle-based sensors requiring costly replacements every two weeks. These recurring consumable expenses, paired with ongoing skin discomfort, create a formidable adherence barrier. Digital health innovator HME Square is dismantling these constraints with GlucoSOUND, a needle-free glucose monitoring platform that converts light and acoustic signals into clinical-grade readings without drawing a single drop of blood.

🛰️ Photoacoustic Precision Engine & Skin-Resilient Architecture

To overcome the physical discomfort of needles and the optical inaccuracies of conventional non-invasive sensors, HME Square harnesses photoacoustic sensing paired with machine learning:

• Acoustic Detection via Harmless Infrared Pulses: When safe infrared light penetrates the skin, subcutaneous glucose absorbs the light energy and generates minute ultrasonic vibrations. Rather than relying strictly on optical reflection—which is easily distorted by skin pigmentation, sweat, or moisture—GlucoSOUND directly captures these acoustic waves through specialized transducers to obtain clean, unscattered signals.

• Clinical-Grade Diagnostic Reliability: By deploying deep learning algorithms to filter signal artifacts and noise, GlucoSOUND achieved a mean absolute relative difference (MARD) of 9.53%, surpassing the 10% clinical accuracy threshold. In clinical evaluations involving 52 participants, 100% of measurements fell within Clarke Error Grid Zones A and B, demonstrating diagnostic precision equivalent to traditional blood sampling without clinical intervention risk.

• Institutional Validation & Hardware Integrity: GlucoSOUND has been designated an Innovative Medical Device by South Korea’s Ministry of Food and Drug Safety (MFDS) and achieved Good Manufacturing Practice (GMP) compliance. Backed by international patents and a CES Innovation Award, the proprietary hardware integrates skin proximity detection, laser monitoring, and fingerprint sensors into a durable, flame-retardant casing.

💡 Zero-Consumable Maintenance & Strategic Global Expansion

By eliminating recurring consumable waste and leveraging streamlined regulatory pathways, HME Square is positioning GlucoSOUND for scalable global adoption:

• Zero-Consumable Maintenance & 66% Cost Reduction: Unlike traditional continuous glucose monitors (CGMs) that generate biohazard waste and demand continuous replacement sensors costing upwards of $3,000 annually, GlucoSOUND features reusable, semi-permanent hardware with zero consumable costs. Delivered through an accessible subscription model of approximately $30 per month, the solution reduces cumulative two-year monitoring costs by over 66% compared to conventional CGMs.

• Strategic U.S. Wellness Market Entry: Seizing upon updated U.S. FDA general wellness guidelines that exempt non-invasive health monitors from burdensome premarket reviews, HME Square is executing an agile dual-track market strategy. The company plans to launch GlucoSOUND directly to consumers and enterprise wellness programs in the U.S. market in 2027, leveraging broad demographic real-world data across diverse skin profiles to de-risk subsequent FDA medical device clearance.

• Form-Factor Evolution Toward Wearables: Following initial deployments of its portable handheld device in public procurement programs, HME Square is advancing an integrated hardware miniaturization roadmap. The company plans to transition its sensing technology into wearable armbands and smartwatch modules, expanding its platform toward multi-biomarker monitoring.

By transforming invasive fingersticks into painless acoustic measurements, HME Square is eliminating the physical and financial hurdles of glycemic control, establishing an accessible foundation for preventative metabolic healthcare. 

Korea Deploys 24/7 Public AI Health Assistant Powered by 5M Datasets